Cargando…
Interleukin-17A (IL-17A): A silent amplifier of COVID-19
One of the hallmarks of COVID-19 is the cytokine storm that provokes primarily pneumonia followed by systemic inflammation. Emerging evidence has identified a potential link between elevated interleukin-17A (IL-17A) levels and disease severity and progression. Considering that per se, IL-17A can act...
Autores principales: | Maione, Francesco, Casillo, Gian Marco, Raucci, Federica, Salvatore, Cristian, Ambrosini, Giovanna, Costa, Luisa, Scarpa, Raffaele, Caso, Francesco, Bucci, Mariarosaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318692/ https://www.ncbi.nlm.nih.gov/pubmed/34364043 http://dx.doi.org/10.1016/j.biopha.2021.111980 |
Ejemplares similares
-
Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms
por: Raucci, Federica, et al.
Publicado: (2020) -
New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A/F function
por: Saviano, Anella, et al.
Publicado: (2023) -
In-depth immunophenotyping data relating to IL-17Ab modulation of circulating Treg/Th17 cells and of in situ infiltrated inflammatory monocytes in the onset of gouty inflammation
por: Raucci, Federica, et al.
Publicado: (2019) -
Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?
por: Casillo, Gian Marco, et al.
Publicado: (2020) -
Commentary: IL-17 in Chronic Inflammation: From Discovery to Targeting
por: Maione, Francesco
Publicado: (2016)